Table of contents

Article

• Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000) (1 November, 2000)

  D E FURST, F C BREEDVELD, G R BURMESTER, J J CROFFORD, P EMERY, M FELDMANN, J R KALDEN, A F KAVANAUGH, E C KEYSTONE, L G KLARESKOG, P E LIPSKY, R N MAINI, A S RUSSELL, D L SCOTT, J S SMOLEN, L B A VAN DE PUTTE, T L VISHER, M H WEISMAN
• Post-transcriptional regulation of tumour necrosis factor α production (1 November, 2000)

  Paul Anderson
• Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB (1 November, 2000)

  Bharat B Aggarwal
• Targeting interleukin 18 with interleukin 18 binding protein (1 November, 2000)

  Charles A Dinarello
• Anti-interleukin 6 receptor antibody treatment in rheumatic disease (1 November, 2000)

  Norihiro Nishimoto, Tadamitsu Kishimoto, Kazuyuki Yoshizaki
• Clinical outcome measures in rheumatoid arthritis (1 November, 2000)

  Piet L C M van Riel, Anke M van Gestel
• Efficacy and toxicity of old and new disease modifying antirheumatic drugs (1 November, 2000)

  Peter Tugwell, Vivian Welch, Maria Suarez-Almazor, Beverley Shea, George Wells
• Which post-marketing database and studies does EMEA require (1 November, 2000)

  Gottfried Kreutz, Leng Heng
• The role of national agencies in the managed introduction of new drugs for arthritis (1 November, 2000)

  Katrina Simister
• Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical update (1 November, 2000)

  Mark W Davis, Ulrich Feige, Alison M Bendele, Steven W Martin, Carl K Edwards
• Update on D2E7: a fully human anti-tumour necrosis factor α monoclonal antibody (1 November, 2000)

  Joachim Kempeni
• Etanercept (Enbrel): update on therapeutic use (1 November, 2000)

  George Spencer-Green
• The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function (1 November, 2000)

  Francis Ka-Ming Chan
• Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFκB in tumour necrosis factor production (1 November, 2000)

  Brian M J Foxwell, Jan Bondeson, Fionula Brennan, Marc Feldmann
• Biological role of interleukin 1 receptor antagonist isoforms (1 November, 2000)

  William P Arend, Carla J Guthridge
• The role of angiogenesis in rheumatoid arthritis: recent developments (1 November, 2000)

  Alisa Erika Koch
• The final pathogenetic steps in focal bone erosions in rheumatoid arthritis (1 November, 2000)

  Steven R Goldring
• Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor α (1 November, 2000)

  Richard O Williams, Marc Feldmann, Ravinder N Maini
• Arguments for interleukin 1 as a target in chronic arthritis (1 November, 2000)

  Wim B van den Berg
• Treatment of spondyloarthropathies with antibodies against tumour necrosis factor α: first clinical and laboratory experiences (1 November, 2000)

  Jürgen Braun, Jian Xiang, Jan Brandt, Hardy Maetzel, Hildrun Haibel, Peihua Wu, Siegfried Kohler, Martin Rudwaleit, Stefanie Siegert, Andreas Radbruch, Andreas Thiel, Joachim Sieper
• Activation of cytokines as a mechanism of disease progression in heart failure (1 November, 2000)

  Biykem Bozkurt
• Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system (1 November, 2000)

  Krzysztof W Selmaj
• Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis (1 November, 2000)

  Michael H Schiff
• Advances in interleukin 2 receptor targeted treatment (1 November, 2000)

  John C Morris, Thomas A Waldmann
• Jaks and Stats as therapeutic targets (1 November, 2000)

  John J O'Shea, Roberta Visconti, Tammy P Cheng, Massimo Gadina
• Future prospects for anti-cytokine treatment (1 November, 2000)

  Marc Feldmann, Jadwiga Miotla, Ewa Paleolog, Richard Williams, Anne-Marie Malfait, Peter Taylor, Fionula M Brennan, Ravinder N Maini